ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Longer-term results back Rhythm’s ultrarare obesity drug
fiercebiotech
May 16, 2018Rhythm Pharma has additional data for its first-in-class obesity therapy setmelanotide—published in the prestigious journal Nature Medicine—showing that the drug’s effects can extend for over a year.
Pharma Sources Insight January 2025
